News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
Eli Lilly (LLY) Announces The Pricing Terms Of Its Cash Tender Offer For Up To $1.6 Billion Aggregate Principal Amount Of Its Outstanding Debt Securities 5/29/2015
BioTie Therapies Corp. Completes The Issuance Of Convertible Notes And Warrants 5/29/2015
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $16 Million 5/29/2015
Combined Shareholders’ Meeting Of IPSEN S.A. Held On 27 May 2015 5/29/2015
ASCO15: Eyebrows Are Raised As Puma Biotech (PBYI) Turns Away Investors, Analyst for ASCO Event 5/29/2015
Biogen (BIIB) 2015 Annual Shareholder Meeting Webcast 5/29/2015
RaySearch Laboratories: Resolutions at the Annual General Meeting 2015 5/29/2015
NeuroVive (Publ) - Amendment Number Of Shares And Votes 5/29/2015
Marrone Bio Innovations, Inc Receives Stay Of Trading Suspension Pending NASDAQ Hearing 5/29/2015
Change In The Number Of Shares And Votes In BioInvent International AB (publ) 5/29/2015
Change Of The Number of Shares And Votes In Karo Bio AB (Publ) 5/29/2015
Cesca Therapeutics Receives Further Notice Of Non-Compliance With Nasdaq Listing Rule 5/29/2015
Number Of Shares And Votes In Orexo AB (ORXOF) 5/29/2015
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself 5/28/2015
NeoStem, Inc. Announces Proposed Public Offering Of Common Stock 5/28/2015
Fate Therapeutics (FATE) Announces Completion Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/28/2015
RXi Pharmaceuticals (RXII) Announces $10 Million Public Offering Of Common Stock And Warrants 5/28/2015
Eli Lilly (LLY) Announces The Early Results Of Its Cash Tender Offer 5/28/2015
RXi Pharmaceuticals (RXII) Announces Proposed Public Offering Of Common Stock And Warrants 5/28/2015
Celsion Corporation (CLSN) Announces $8 Million At-The-Market Registered Direct Offering 5/28/2015
NeoStem, Inc. Prices $25,000,000 Public Offering Of Common Stock 5/28/2015
Neptune Technologies & Bioressources Inc. Announces New Board Of Director Nominees For Election At Annual And Special Meeting Of Shareholders 5/28/2015
Agilent Technologies Inc. (A) Authorizes New Share Repurchase Program 5/28/2015
Aurinia (ISA.TO) Announces Results Of Annual General Meeting 5/28/2015
Agenus (AGEN) Announces Closing Of Public Offering And Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock 5/28/2015
RXi Pharmaceuticals (RXII) Provides An Update On Series A And Series A-1 Preferred Stock 5/27/2015
Tianyin Pharmaceutical Co, Inc. Adjourned Its 2014 Annual Shareholder Meeting And Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 5/27/2015
Israeli Biotech Company Vaxil Bio To List On Toronto Stock Exchange Venture Through Reverse Takeover With Emerge Resources 5/27/2015
Cellectar Biosciences  (NVLT) Announces Intent To Adjourn Annual Meeting Of Stockholders 5/27/2015
IGI Laboratories, Inc. Updates Business Outlook 5/27/2015
Bristol-Myers Squibb (BMY) Announces The Expiration Of Its Cash Tender Offer 5/27/2015
Addex Therapeutics (ADXN.SW) Annual General Meeting Scheduled For 11 June 2015 5/27/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 5/26/2015
Immune Design Corporation (IMDZ) To Host June 2 Investor And Analyst Event In NYC 5/26/2015
Resolutions Of The Annual General Meeting Of BioTie Therapies Corp. And Organization Of The Board 5/26/2015
Suven Life Sciences Ltd’s Income Increased By 3% And PAT Lower By 25% For The Year Ended March 2015 5/26/2015
Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5/26/2015
Momenta (MNTA) Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares And Closing Of Public Offering Of Common Stock 5/26/2015
Resolutions Adopted By The Extraordinary General Meeting In Karo Bio AB Held On May 25, 2015 5/26/2015
Skystar Bio-Pharmaceutical (CGPN) Announces Receipt Of Nasdaq Non-Compliance Letter Due To Delay In Filing Form 10-Q 5/26/2015
TxCell Announces That All Resolutions Supported By The Board Of Directors Were Approved During Its Annual Meeting Of Shareholders 5/26/2015
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Warrants 5/22/2015
Valeant (VRX) Chief Calls Recent Biotech M&A "Bit of a Bubble" 5/22/2015
Amarantus BioSciences, Inc. Effects Capital Restructuring In Anticipation Of National Exchange Listing 5/22/2015
CEL-SCI (CVM) Prices Up To $16 Million Public Offering Of Common Stock And Warrants 5/22/2015
NovaBay Pharmaceuticals, Inc. (NBY) Announces $6.86 Million "At Market" Private Placement 5/22/2015
Atrion (ATRI) Declares Quarterly Cash Dividend 5/22/2015
Aldeyra Therapeutics (ALDX) Announces Closing Of Common Stock Offering 5/22/2015
Digital Specialty Chemicals Receives Investment From Intel Capital 5/22/2015
Karolinska Development AB's Annual General Meeting 2015 5/21/2015
Agenus (AGEN) Announces Pricing Of Its Public Offering Of Common Stock 5/21/2015
Dicerna (DRNA) Announces Pricing Of Follow-On Offering Of Common Stock 5/21/2015
Fate Therapeutics (FATE) Announces Pricing Of Public Offering Of Common Stock 5/21/2015
Portage Biotech Announces Proposed Private Placement 5/20/2015
Valeant (VRX) Announces 2015 Annual Meeting Results 5/20/2015
Momenta (MNTA) Announces Pricing Of Public Offering Of Common Stock 5/20/2015
CohBar Announces Commencement Of Trading On The OTCQX Marketplace 5/20/2015
Quintiles Transnational Corp. Announces Closing Of Secondary Public Offering And Repurchase Of Common Stock 5/20/2015
Helix Biopharma (TSX:HBP) Retains The Trout Group As Investor Relations Advisor 5/20/2015
Galapagos (GLPG.BR) Announces Capital Increase 5/20/2015
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? 5/19/2015
Momenta Pharmaceuticals, Inc. (MNTA) Announces Proposed Public Offering Of Common Stock 5/19/2015
Billionaire Doubles Down On Valeant (VRX) 5/19/2015
Pluristem Therapeutics (PSTI) To Conduct Conference At Tel Aviv Stock Exchange To Review Regulatory Progress And Company Strategy 5/19/2015
Fate Therapeutics (FATE) Announces Proposed Public Offering Of Common Stock 5/19/2015
Lucideon (Formerly Known As CERAM) To Host Free Seminar – "Sampling Best Practice For Improved Business Performance" – 12 June 2015 5/19/2015
Citi Appointed Depositary Bank For Adaptimmune’s ADR Programme 5/19/2015
Dicerna (DRNA) Announces Follow-On Public Offering Of Common Stock 5/19/2015
NeuroVive: NeuroVive Announces Prospectus Regarding Admission To Trading Of New Shares 5/19/2015
Easton Pharmaceuticals (OP: EAPH) Letter To Shareholders 5/19/2015
Pfizer (PFE) Invites Public To View And Listen To Webcast Of June 2 Conference Call With Analysts To Review Oncology Business And ASCO Data Presentations 5/19/2015
GW Pharma (GWPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional American Depositary Shares 5/18/2015
Bacterin International, Inc. Sets Annual Meeting And Record Dates 5/18/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 5/18/2015
Galapagos (GLPG.BR) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/18/2015
Akorn, Inc. (AKN) Receives NASDAQ Delinquency Notice 5/18/2015
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/18/2015
Baxter International (BAX) And Baxalta Highlight Business Strategies At Investor Conferences 5/18/2015
BioInvent (BOVNF): BioInvent’s Rights Issue Oversubscribed 5/18/2015
Atossa Genetics, Inc. (ATOS) To Host Conference Call Today, Monday, May 18, 2015 At 4:30pm Eastern Time To Provide Company Update 5/18/2015
Telesta Therapeutics Publishes Its Nine Month Financial Results To March 31, 2015 And Provides Corporate Updates 5/15/2015
INC Research, Inc. (INCR) Completes Secondary Offering, Stock Repurchase And Debt Refinancing; Updates 2015 Business Outlook 5/15/2015
Amgen (AMGN) Announces Voting Results Of Annual Meeting Of Stockholders 5/15/2015
Galectin Therapeutics To Webcast Corporate Update Following Annual Meeting Of Stockholders 5/15/2015
CymaBay Therapeutics To Ring The Nasdaq Stock Market Closing Bell 5/15/2015
Tekla Life Sciences Investors Declared Stock Distribution 5/15/2015
Cystic Fibrosis Biotech Nivalis Therapeutics Files for $60 Million IPO 5/14/2015
Emergent BioSolutions (EBS) To Hold Annual Meeting Of Stockholders Thursday May 21, 2015 At 9:00 AM Eastern; Webcast Will Be Available 5/14/2015
Dow Chemical  (DOW) Announces Results From Annual Stockholder Meeting 5/14/2015
Hikma Pharmaceuticals (HIK.L) Release: AGM Trading Update 5/14/2015
Cipher Pharma (DND.TO) Reports Voting Results From Annual And Special Meeting Of Shareholders 5/14/2015
Dow Announces Results From Annual Stockholder Meeting 5/14/2015
Agilent Technologies Inc. (A) To Host Webcast Of Analyst And Investor Meeting 5/14/2015
Quintiles (Q) Announces Pricing Of Secondary Public Offering 5/14/2015
Spectrum Pharmaceuticals, Inc. (SPPI) Commits To Review Shareholder Proposal 5/14/2015
A Battle is Brewing Between Keryx (KERX)'s Largest Backer and Short Investors 5/13/2015
aTyr Pharma Announces Closing Of Initial Public Offering 5/13/2015
Neurocrine Biosciences, Inc. (NBIX) To Host Analyst And Investor Day In New York City On May 21, 2015 5/13/2015
Valeant (VRX) To Webcast 2015 Annual Meeting Of Shareholders 5/13/2015
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 2 June 2015 5/13/2015
Report From The 2015 Annual General Meeting In Aerocrine 5/13/2015
Bristol-Myers Squibb (BMY) Announces The Pricing Terms Of Its Cash Tender Offer For Up To $500 Million Aggregate Principal Amount Of Its Outstanding Debt Securities 5/13/2015
Onxeo: Publication Of A Letter To Shareholders – May 2015 5/13/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 5/12/2015
Eli Lilly (LLY) Announces Cash Tender Offer For Up To $1.6 Billion Aggregate Principal Amount Of Its Outstanding Debt Securities And The Redemption Of Its 6.57% Notes Due 2016 5/12/2015
LEERINK Partners Expands Investment Banking Franchise 5/12/2015
Bristol-Myers Squibb (BMY) Announces The Early Results Of Its Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities; Increases The Maximum Amount Of The Tender Offer 5/12/2015
Skyepharma PLC (SKYEF) AGM Trading Update 5/12/2015
Moberg Pharma AB (Formerly known as Moberg Derma): Bulletin from Moberg Pharma’s Annual General Meeting 2014 5/12/2015
MYOS (MYOS) To Host Conference Call To Discuss Quarterly Update And Management Highlights 5/12/2015
Antares Pharma, Inc. (ATRS) Announces Closing Of Public Offering Of Common Stock 5/12/2015
BioDelivery Sciences International (BDSI) Provides Corporate Update and Reports First Quarter 2015 Financial Results 5/11/2015
BioScrip (BIOS) Announces Proposal To Commence Exchange Offer 5/11/2015
GenSpera Provides Corporate Update 5/11/2015
M-Pharmaceutical - Shareholder Update 5/11/2015
Acasti Pharma Receives Extension to Regain Compliance With NASDAQ Minimum Bid Price Rule 5/11/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 5/11/2015
HEALTHSOUTH Declares Dividend On Common Stock 5/8/2015
China Cord Blood Corporation Receives Notice Of Transactions Regarding Its 7% Senior Convertible Notes Due 2017 Held By Cordlife And Magnum And Its Ordinary Shares Held By CordLife Ltd. 5/8/2015
Celator Pharmaceuticals, Inc. Announces Business Update And First Quarter 2015 Financial Results 5/8/2015
Aldeyra Therapeutics (ALDX) Announces Pricing Of Follow-On Public Offering Of Common Stock 5/8/2015
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend 5/8/2015
Provectus Biopharmaceuticals Inc. Updates Market On Business Developments 5/8/2015
Manhattan Scientifics, Inc. Issues Letter From The New President Of Its Senior Scientific Subsidiary 5/8/2015
Golden Meditech Proposes To Purchase CCBC Convertible Notes Held By Magnum And CCBC Convertible Notes And CCBC Shares Held By CGL 5/8/2015
Bulletin From Annual General Meeting In Recipharm AB 5/8/2015
Two Under-the-Radar Updates Pfizer (PFE) Investors Need to Know About 5/7/2015
GENFIT (ALGFT): Ordinary General Shareholders’ Meeting Of June 3, 2015 – Availability Of Preparatory Documents 5/7/2015
aTyr Pharma Announces Pricing Of Initial Public Offering 5/7/2015
IMRIS Announces Postponement Of Its Annual Meeting Of Shareholders And Release Of First Quarter 2015 Financial Results And Conference Call 5/7/2015
Kythera (KYTH) Grants Stock Options Under Inducement Program 5/7/2015
Asterias Biotherapeutics To Host Investor Meeting To Review Clinical Development Strategy For AST-OPC1 In Spinal Cord Injury 5/7/2015
Affimed Therapeutics AG (AFMD) Announces Pricing Of Public Offering Of Common Stock 5/7/2015
GENFIT (ALGFT) Announces Its Turnover And Cash Situation As Of March 31, 2015 5/7/2015
Zivo Bioscience, Inc. Announces Increase In Credit Facility From Primary Lender And Notice Of Convertible Debt Conversion 5/7/2015
Stevia First Corp. Announces $1.5 Million Private Placement With Institutional Investors 5/7/2015
Horizon Pharma (HZNP) Announces Results Of Tender Offer 5/7/2015
Edwards Lifesciences (EW) To Webcast Annual Meeting Of Stockholders 5/7/2015
INC Research, Inc. (INCR) Announces Pricing Of Secondary Offering 5/7/2015
IDEXX Laboratories, Inc. (IDXX) Announces Two-For-One Stock Split And Increase In Share Repurchase Program 5/6/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Antares Pharma, Inc. (ATRS) Announces Pricing Of Public Offering Of Common Stock 5/6/2015
Paratek Pharmaceuticals, Inc. Announces Closing Of Common Stock Offering 5/6/2015
Advaxis, Inc. Announces Closing Public Offering Of Common Stock With Gross Proceeds Totaling $53.2 Million 5/6/2015
Galapagos (GLPG.BR) Announces Launch Of Proposed Global Offering 5/6/2015
Galapagos (GLPG.BR) Listed 10 Years On Euronext Amsterdam And Brussels 5/6/2015
Medivir AB (MVRBF)’s Board Of Directors Has Resolved To Repurchase Own Shares 5/6/2015
Thermo Fisher Scientific (TMO) To Host Analyst Meeting 5/6/2015
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock 5/6/2015
pSivida (PSDV)'s Drug Delivery Technology Business Model Draws Comparison to Regeneron (REGN) Blockbuster Success 5/6/2015
SV Bank Exec: New Companies Are Booming, As “Frothy” Market Looks to Novel Science 5/5/2015
Bio-Techne (TECH) Declares Dividend 5/5/2015
Aldeyra Therapeutics (ALDX) Launches Proposed Follow-On Public Offering Of Common Stock 5/5/2015
Cytori Therapeutics, Inc. (CYTX) Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing 5/5/2015
Baxter International (BAX) Declares Quarterly Dividend 5/5/2015
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015
Inovio Pharmaceuticals (INO) Closes $87.4 Million Underwritten Financing 5/5/2015
Blueprint Medicines (BPMC) Announces Closing of Initial Public Offering 5/5/2015
Five Things to Take Away From Vertex (VRTX)'s Q1 5/4/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
China Cord Blood Corporation Receives Notice Of A Transaction Regarding Its 7% Senior Convertible Notes Due 2017 Held By KKR 5/4/2015
EcoScience Corporation Significantly Reduces Number Of Outstanding Common Stock 5/4/2015
Burcon Nutrascience Corp. (BU) Announces Completion Of Over-Subscribed Rights Offering 5/4/2015
Tikcro Technologies Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Generex Biotechnology Corporation (GNBT) Announces Intention To Dividend A Portion Of Anticipated SMFI Securities To Its Stockholders Upon A Reverse Stock Split 5/4/2015
Webcast Alert: Heska Corporation (HSKA)'s Annual Meeting Of Stockholders Webcast 5/4/2015
Affimed Therapeutics AG (AFMD) Announces Proposed Public Offering Of Common Stock 5/4/2015
Macrocure (MCUR) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Kite Pharma (KITE) CEO Avoids Big Tax Bite By Exercising Options Before IPO 5/4/2015
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $25 Million Public Offering 5/1/2015
Lion Biotechnologies, Inc. Announces Pricing Of Secondary Offering Of Shares By Selling Stockholders 5/1/2015
TetraLogic Pharmaceuticals (TLOG) Announces Public Offering Of Common Stock 5/1/2015
BioAmber Inc. Announces Public Offering Of Common Stock 5/1/2015
WuXi PharmaTech Co., Ltd. Announces Receipt Of Proposal 5/1/2015
Northwest Biotherapeutics (NWBO) Rakes In $28.5 Million 5/1/2015
Quintiles (Q) Announces Proposed Offering Of $800 Million Of Senior Notes 5/1/2015
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/1/2015
NephroGenex (NRX) Announces Proposed Offering Of Common Stock 5/1/2015
Juniper Pharmaceuticals Reschedules Annual General Meeting 4/30/2015
Pfenex (PFNX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/30/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Share Purchase Agreement With Lincoln Park Capital Fund, LLC 4/30/2015
Lipocine Inc. (LPCN) Prices $30.2 Million Public Offering Of Common Stock 4/30/2015
Lipocine Inc. (LPCN) Announces Closing Of $34.8 Million Common Stock Offering 4/30/2015
Inovio Pharmaceuticals (INO) Announces Public Offering Of Common Stock 4/30/2015
StemCells (STEM) Announces Closing Of $25 Million Public Offering 4/30/2015
Advaxis, Inc. Announces Proposed Public Offering Of Common Stock 4/30/2015
Inovio Pharmaceuticals (INO) Announces Pricing Of Public Offering Of Common Stock 4/30/2015
Paratek Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of 2,860,000 Shares Of Common Stock 4/30/2015
Advaxis, Inc. Prices $53 Million Public Offering Of Common Stock 4/30/2015
DS Healthcare Group Regains Compliance With Nasdaq Listing Requirements 4/30/2015
Neptune Technologies & Bioressources Inc. Provides Business Update 4/30/2015
Invitation - Presentation Of Sobi's First Quarter 2015 4/30/2015
Bristol-Myers Squibb (BMY) Prices €1.15 Billion Of Senior Notes 4/30/2015
WuXi PharmaTech Co., Ltd. Receives $3.2 Billion Privatization Offer 4/30/2015
Helix Biopharma (TSX:HBP) Closes Additional Private Placement Financing 4/30/2015
Teva (TEVA) Sends Letter To Mylan (MYL) Board 4/30/2015
Sinovac Biotech Ltd. (SVA) Files 2014 Annual Report On Form 20-F 4/29/2015
GW Pharma (GWPH) Raises $179.2 Million NASDAQ Cash 4/29/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Extension To Regain Compliance With Nasdaq's Minimum Bid Price Rule 4/29/2015
Novogen Limited (NVGN) Completes The Private Placement Of Equity 4/29/2015



//-->